Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

MVZ für Hämatologie und Onkologie der MVZ-Medizinisches Versorgungszentrum Mülheim GmbH

Research site

Germany Schulstraße 13, 45468 Mülheim an der Ruhr, Germany

  • Neoplasm malignant
  • Adult patients

About Specializations

MVZ für Hämatologie und Onkologie der MVZ-Medizinisches Versorgungszentrum Mülheim GmbH in Mülheim an der Ruhr, Germany specialises in clinical trials of conditions such as Neoplasm malignant, and other specialisations. This site conducts important research.

Main research areas of the site

Hodgkin Lymphoma Research

The MVZ für Hämatologie und Onkologie focuses on advanced stage Hodgkin lymphoma within the broader field of neoplasms. The trial evaluates a modified chemotherapy regimen to lower toxicity while preserving effectiveness.

  • Reduced treatment‑related morbidity
  • Non‑inferior progression‑free survival
  • Comparison of BrECADD versus escalated BEACOPP
  • PET‑guided radiotherapy for residual disease

This work aims to provide safer treatment options for patients in Mülheim and adds valuable data to international oncology research.

Triple‑Negative Breast Cancer Study

In early breast cancer, specifically the triple‑negative subtype, the centre investigates the addition of atezolizumab to standard chemotherapy to improve event‑free survival.

  • Neoadjuvant immunotherapy combined with chemotherapy
  • Adjuvant continuation of atezolizumab
  • Event‑free survival as primary endpoint
  • Double‑blind randomized design

Results could expand therapeutic options for patients with aggressive breast cancer and guide future treatment guidelines.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Schulstraße 1345468 Mülheim an der RuhrGermany
Open in maps ↗
Recruiting now
no trials
Conditions studied
1

More sites in Mülheim an der RuhrGermany

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Study on Reducing Side Effects in Advanced Hodgkin Lymphoma Using Brentuximab Vedotin and Drug Combination for Newly Diagnosed Patients

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bleomycin Sulfate
  • Sponsor:University Of Cologne

Neoplasm malignant

Not recruiting

Study on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:NSABP Foundation Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.